Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | Note 10 — Stock Incentives In April 2014, the Orchids Paper Products Company 2014 Stock Incentive Plan (the “2014 Plan”) was approved. The 2014 Plan replaced the Orchids Paper Products Company 2005 Stock Incentive Plan (the “2005 Plan”) and provides for the granting of stock options and other stock based awards to employees and Board members selected by the Board’s Compensation Committee. A total of 400,000 shares may be issued pursuant to the 2014 Plan. As of September 30, 2015, there were 286,400 shares available for issuance under the 2014 Plan. Stock Options with Time-Based Vesting Conditions The grant date fair value of the following option grants was estimated using the Black-Scholes option valuation model. Option valuation models require the input of highly subjective assumptions including the expected stock price volatility. The following table details the options granted to certain members of the Board of Directors and management that were valued using the Black-Scholes valuation model and the assumptions used in the valuation model for those grants during the nine months ended September 30, 2015 and 2014: Grant Number Exercise Grant Date Risk-Free Estimated Dividend Expected Date of Shares Price Fair Value Interest Rate Volatility Yield Life (years) May-14 35,000 $ 29.65 $ 7.50 2.62 % 41 % 4.72 % 5 June-14 5,000 $ 30.09 $ 7.67 2.63 % 41 % 4.65 % 5 May-15 40,000 $ 22.485 $ 4.64 2.13 % 40 % 6.23 % 5 The Company expenses the cost of these options granted over the vesting period of the option based on the grant-date fair value of the award. Stock Options with Market-Based Vesting Conditions During the first nine months of 2015 and 2014, the Board of Directors granted options to purchase 28,600 and 145,000 shares, respectively, of the Company’s common stock to certain members of management. These options will become exercisable in four equal tranches, if at all, if and when the share price of the common stock closes at a certain percentage of the purchase price of the option for three consecutive business days, in accordance with the following vesting schedule: Share price required to achieve vesting 2014 options 2015 options Tranche 1 $ 34.788 $ 29.560 Tranche 2 $ 42.350 $ 36.000 Tranche 3 $ 51.425 $ 43.710 Tranche 4 $ 60.500 $ 51.430 Any unvested portion of the 2014 options shall expire five years from the date of grant. Any unvested portion of the 2015 options shall expire on November 8, 2018. Both the 2014 options and the 2015 options shall terminate ten years after the date of grant. As these options include a market condition, the grant date fair value and implicit service period of these option grants were estimated using a Monte Carlo option valuation model. The following table details the options granted to certain members of management that were valued using the Monte Carlo valuation model and the assumptions used in the valuation model for those grants during the nine months ended September 30, 2015 and 2014: Derived Risk-Free Service Grant Number Exercise Grant Date Interest Estimated Dividend Expected Period Date of Shares Price Fair Value Rate Volatility Yield Life (years) (years) January 14 - Tranche 1 10,000 $ 31.125 $ 5.64 1.98 % 31 % 4.50 % 5.15 0.31 January 14 - Tranche 2 10,000 $ 31.125 $ 5.46 1.98 % 31 % 4.50 % 5.58 1.15 January 14 - Tranche 3 10,000 $ 31.125 $ 5.03 1.98 % 31 % 4.50 % 5.97 1.94 January 14 - Tranche 4 10,000 $ 31.125 $ 4.27 1.98 % 31 % 4.50 % 6.25 2.50 February 14 - Tranche 1 25,000 $ 30.88 $ 5.51 1.98 % 31 % 4.60 % 5.17 0.35 February 14 - Tranche 2 25,000 $ 30.88 $ 5.35 1.98 % 31 % 4.60 % 5.60 1.19 February 14 - Tranche 3 25,000 $ 30.88 $ 4.88 1.98 % 31 % 4.60 % 5.99 1.98 February 14 - Tranche 4 25,000 $ 30.88 $ 4.15 1.98 % 31 % 4.60 % 6.27 2.54 May 14 - Tranche 1 1,250 $ 28.185 $ 5.06 2.03 % 31 % 4.70 % 5.36 0.71 May 14 - Tranche 2 1,250 $ 28.185 $ 4.74 2.03 % 31 % 4.70 % 5.78 1.56 May 14 - Tranche 3 1,250 $ 28.185 $ 4.02 2.03 % 31 % 4.70 % 6.14 2.29 May 14 - Tranche 4 1,250 $ 28.185 $ 3.29 2.03 % 31 % 4.70 % 6.39 2.79 September 15 - Tranche 1 7,150 $ 25.24 $ 4.44 1.82 % 34 % 5.20 % 5.20 0.40 September 15 - Tranche 2 7,150 $ 25.24 $ 3.92 1.82 % 34 % 5.20 % 5.51 1.02 September 15 - Tranche 3 7,150 $ 25.24 $ 3.11 1.82 % 34 % 5.20 % 5.77 1.54 September 15 - Tranche 4 7,150 $ 25.24 $ 2.36 1.82 % 34 % 5.20 % 5.93 1.87 The Company expenses the cost of these options granted over the implicit, or derived, service period of the option based on the grant-date fair value of the award. Options Issued Outside of the 2014 Plan In April 2014, the Company’s stockholders voted to approve the options granted to Mr. Jeffrey S. Schoen, the Company’s President and Chief Executive Officer, on November 8, 2013. Upon his appointment as an officer of the Company, Mr. Schoen was granted an option to purchase up to 400,000 shares of the common stock of the Company at a purchase price of $30.25 per share. The option will become exercisable, if at all, if and when the share price of the Company’s common stock closes at a certain percentage of the purchase price of the option for three consecutive business days, in accordance with the following vesting schedule: Share price closes at or above the following percentage of the purchase price for the Option Number of shares that become vested 115% (share price $34.788) 100,000 140% (share price $42.35) 100,000 170% (share price $51.425) 100,000 200% (share price $60.50) 100,000 These options were granted outside of the 2005 Plan or the 2014 Plan. Any unvested portion of the option shall expire five years from the date of grant and the option shall terminate ten years after the date of grant. The Company used a Monte Carlo option valuation model to estimate the grant date fair value of each tranche of 100,000 options, as they include a market condition. The Company will expense the cost of the options granted over the implicit service period of the options based on the completed Monte Carlo models. The following table details the assumptions used in the valuation model for the options granted to Mr. Schoen: Number Exercise Grant Date Risk-Free I Rate Estimated Dividend Expected Derived Service (years) Tranche 1 100,000 $ 30.25 $ 5.18 2.10 % 30 % 4.60 % 4.99 0.40 Tranche 2 100,000 $ 30.25 $ 5.04 2.10 % 30 % 4.60 % 5.42 1.25 Tranche 3 100,000 $ 30.25 $ 4.31 2.10 % 30 % 4.60 % 5.79 2.00 Tranche 4 100,000 $ 30.25 $ 3.50 2.10 % 30 % 4.60 % 6.04 2.50 Total Option Expense The Company recognized the following expenses related to all options granted under the 2005 Plan, the 2014 Plan and the Schoen options: Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Time-Based Vesting Options $ 1,000 $ 1,000 $ 188,000 $ 307,000 Market-Based Vesting Options 77,000 427,000 555,000 1,264,000 Total compensation expense related to stock options $ 78,000 $ 428,000 $ 743,000 $ 1,571,000 Future Expected Market-Based Stock Option Expense The grant of options that vest based on a market condition will have a material impact on the Company’s results of operations. Based on the derived service periods of the options, the Company expects to expense the compensation cost related to these options as shown in the following table. However, if the market condition is achieved for any tranche of these options prior to the end of the derived service period, all remaining expense related to that tranche would be recognized in the period in which the market condition is achieved. 2015 2015 2016 2017 Q1 Q2 Q3 Q4 Total Total Total (in thousands) Tranche 1 $ - $ - $ - $ 26 $ 26 $ 5 $ - Tranche 2 134 104 1 10 249 19 $ - Tranche 3 73 72 47 73 265 73 $ 3 Tranche 4 47 48 30 48 173 138 $ 5 Total expense $ 254 $ 224 $ 78 $ 157 $ 713 $ 235 $ 8 Restricted Stock In February 2013, the Company granted 16,000 shares of restricted stock to certain employees under the 2005 Plan. These awards were valued at the arithmetic mean of the high and low market price of the Company’s stock on the grant date, which was $21.695 per share, and vest ratably over a three year period beginning on the first anniversary of the grant date. During the nine months ended September 30, 2015 and 2014, 334 and 667 of these shares were forfeited, respectively. In 2013, 8,000 of these shares were forfeited. The first third of unforfeited shares, or 2,666 shares, vested in February 2014. The second third of unforfeited shares, or 2,333 shares, vested in February 2015. The Company expenses the cost of restricted stock granted over the vesting period of the shares based on the grant-date fair value of the award. The Company recognized expense of $8,000 and $9,000 for the three-month periods ended September 30, 2015 and 2014, respectively, and $34,000 and $38,000 for the nine-month periods ended September 30, 2015 and 2014, respectively, related to shares of restricted stock granted. |